Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-25 @ 2:14 PM
NCT ID:
NCT02988466
Group ID:
EG001
Title:
CLOSED Arm B: Haplo-HCT ≥55 Years Old
Description:
Reduced-intensity conditioning and transplantation of human leukocyte antigen (HLA) -haploidentical related donor stem cells for patients ≥55 years old or younger with hematopoietic cell transplantation Comorbidity Index (HCT-CI) ≥3.
Haplo HCT ≥55 years old: - Fludarabine (Flu)
* Cyclophosphamide (Cy)
* Melphalan (Mel): Dose reduction by 30%
* Total body irradiation (TBI)
* Non-T-cell depleted donor bone marrow stem cell infusion
GVHD Prophylaxis: - Cyclophosphamide (Cy)
* Tacrolimus (Tac)
* Mycophenolate mofetil (MMF)
Deaths Number Affected:
13
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
21
Other Number Affected:
11
Other Number At Risk:
21
Study:
NCT02988466
Results Section:
NCT02988466
Adverse Events Module:
NCT02988466